Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Antibiotic-associated diarrhea (AAD) is a common complication of broad-spectrum antibiotic use.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant nosocomial pathogen.
• The role of MRSA as a cause of AAD requires further investigation.

Purpose of the Study:

• To investigate the role of MRSA in antibiotic-associated diarrhea.
• To describe the clinical characteristics and management of MRSA-induced AAD.
• To highlight the importance of early diagnosis and infection control.

Main Methods:

• Retrospective case series of 10 patients with AAD at The Royal Melbourne Hospital over 12 months.
• Diagnosis based on Gram stain of stool smears, stool cultures for MRSA, and exclusion of other pathogens.
• Treatment efficacy assessed by clinical response and stool clearance of MRSA.

Main Results:

• MRSA was identified as the causative agent in 10 cases of AAD.
• Patients had significant underlying conditions and received multiple broad-spectrum antibiotics.
• Diarrhea typically resolved with vancomycin or bacitracin, with subsequent clearance of MRSA from stools.

Conclusions:

• MRSA can cause antibiotic-associated diarrhea, particularly in immunocompromised patients.
• Early diagnosis, appropriate antibiotic therapy (vancomycin/bacitracin), and isolation are essential for patient management.
• MRSA-associated diarrhea poses a significant cross-infection risk in healthcare settings.